Quick Takeaways
- ArrowMark Colorado Holdings LLC filed SCHEDULE 13G/A for PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 (PMVP).
- Disclosed ownership: 5.8%.
- Date of event: 31 Dec 2025.
ArrowMark Colorado Holdings LLC - 31 Dec 2025 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 (PMVP)
- Filing Manager
- ArrowMark Colorado Holdings LLC
- Reporting Manager
- ArrowMark Colorado Holdings, LLC
- Symbol
- PMVP
- Shares outstanding
- 53,185,766 shares
- Disclosed Ownership
- 3,090,093 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:36:12 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ArrowMark Colorado Holdings LLC disclosed 5.8% ownership in PMV Pharmaceuticals, Inc. Common stock, par value $0.00001 (PMVP) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ArrowMark Colorado Holdings, LLC | 5.8% | 3,090,093 | 3,090,093 | 0 | Richard Grove | Richard Grove | Chief Compliance Officer |